Eltek's Q1 Results: Coating-Line Progress and Margin Recovery in Focus

What happened

Eltek reported Q1 2026 results, marking another checkpoint in its $15M capacity expansion plan. The company's narrative continues to hinge on commissioning of the new coating line and restoring gross margins from the trough seen in 2025. While top-line revenue held steady with defense mix around 63%, the key question remains whether operating metrics improved enough to validate management's timeline. The report did not disclose material slippage in the coating-line schedule, but the absence of clear margin inflection suggests investors should remain skeptical. Until gross margins demonstrably revert toward 20% and FX volatility subsides, the stock remains a high-risk bet on execution rather than demand.

Implication

The Q1 results are a data point but not a catalyst. Maintain WAIT rating; re-assess after Q2 2026 when the capacity program is due to conclude. Entry near $8.00 offers a better risk/reward if disappointments occur.

Thesis delta

No material shift. The base case remains valid: require gross margin ≥20% and FX expense ≤$0.2M for two quarters. The lack of explicit negative surprises in Q1 keeps the 50% probability base case intact, but the absence of strong positive news keeps the call on hold.